Medidata Study Experience
-
New Therapeutic And Diagnostic Avenues In Breast Cancer
1/24/2023
This podcast discusses an important metastatic breast cancer study that was recently published in the New England Journal of Medicine and presented at ASCO - the American Society of Clinical Oncology in June 2022.
-
A New Avenue In Breast Cancer Therapeutics
1/23/2023
Clinical trial findings may have unlocked a groundbreaking opportunity for breast cancer patients: beneficial therapy for HER2-negative patients with HER2-directed antibody-drug conjugates.
-
Rave eTMF - Simplify Trial Oversight With Unified Document Management
1/2/2023
Your Trial Master File (TMF) complexity is growing. It’s not uncommon to upload thousands of documents per day, subject to strict regulatory requirements for filing, and under aggressive timelines. Rave eTMF is a global, secure collaboration platform to seamlessly manage Trial Master File content so it is always contemporaneous with the study.
-
3 Data Linkage Use Cases To Future Proof Your Clinical Trials
12/20/2022
Discover why access to compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes.
-
The Future Of Data Linkage In Clinical Trial Evidence Generation
12/20/2022
Explore key questions about the future of AI and data linkage in clinical trial evidence generation.
-
The Regulatory Grade External Control Arm To Power Your Clinical Trials
12/9/2022
Examine the growing role of external control arms in clinical trials, including the distinctions between control groups that use real-world data and those that use historical clinical trial data.
-
Imunon Phase IB Ovarian Cancer Study Shows Strong Progression-Free Survival Treatment Effect Using A Synthetic Control Arm
12/8/2022
Explore how Imunon used a control arm among stage III/IV ovarian cancer patients in their clinical trial.
-
Drive Possibility Forward
12/8/2022
Medidata AI provides unparalleled clinical data, advanced analytics, and industry expertise to help reimagine what is possible through uncovering breakthrough insights, making confident decisions, and pursuing continuous innovation.
-
Medidata AI Labs History
12/8/2022
Medidata Al Labs focuses on working closely with clients to answer important questions as they work to bring therapies to
patients faster. -
A Mid-Sized Sponsor Increased Site Count By 50% In A Rare Disease Clinical Trial
12/8/2022
In this case study, explore how a mid-sized sponsor chose high-performing sites based on reliable data to set their trial up for success.